ArticleBMC cancer2023

Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study.

Xingxiang Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.